https://www.selleckchem.com/pr....oducts/pkr-in-c16.ht
98, exceeding the threshold criterion of CFI 0.9 indicating factor validity. A secondary exploratory factor analysis provided further support to the consistency between the factor structures of the Hebrew and Reference Standard versions of the UDysRS. Conclusion The UDysRS Hebrew version shows strong clinimetric properties and fulfills the criteria for designation as an official International Parkinson and Movement Disorder Society-approved translation for use in clinical and research settings.The neuropeptide arginine-vasopress
Like
Comment
Share
